The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 33, No. 7, pp. 808-812. DOI 10.1345/aph.18237
© 1999 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shelton, P.
Right arrow Articles by Brooks, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shelton, P.
Right arrow Articles by Brooks, V.

Research Articles

Estrogen for dementia-related aggression in elderly men

PS Shelton and VG Brooks

OBJECTIVE: To report the use of conjugated estrogens for aggression in two elderly men with dementia and to review the available literature relating to estrogen use for aggression in the elderly. CASE SUMMARIES: Case 1. A 78-year-old white man had probable Alzheimer dementia and aggression (verbal and physical) that was nonresponsive to antipsychotic, antidepressant, and mood stabilizer therapy. However, conjugated estrogens 1.875 mg/d reduced his physical aggression, as evidenced by a 75% decline in aggressive episodes, per 24-hour nursing reports and progress notes. Case 2. A 78-year-old African-American man with vascular dementia, physical aggression, and sexual inappropriateness was unsuccessfully managed with several antipsychotic and benzodiazepine trials. He did, however, exhibit a decline in physical and sexual aggression by 80%, as well as a 55% reduction in sexual comments, after daily treatment with conjugated estrogens 0.625 mg. Estrogen was well tolerated by both patients. DATA SOURCES: MEDLINE (January 1966-May 1998) and PsychLit (January 1974-May 1998) database searches were performed to identify case reports, letters, or clinical trials discussing estrogen use in aggressive elderly patients. CONCLUSIONS: As with previous reports, these cases suggest that conjugated estrogens may be used to reduce physical and sexual aggression associated with dementia in elderly men. Additional study is needed to determine the exact role of this alternative pharmacologic intervention.


This article has been cited by other articles:


Home page
 Alcohol AlcoholHome page
C. J. P. Eriksson, B. von der Pahlen, T. Sarkola, and K. Seppa
OESTRADIOL AND HUMAN MALE ALCOHOL-RELATED AGGRESSION
Alcohol Alcohol., November 1, 2003; 38(6): 589 - 596.
[Abstract] [Full Text] [PDF]

Home page
 J. Neuropsychiatry Clin. Neurosi.Home page
C. Orengo, M. E. Kunik, V. Molinari, K. Wristers, and S. C. Yudofsky
Do Testosterone Levels Relate to Aggression in Elderly Men With Dementia?
J Neuropsychiatry Clin Neurosci, May 1, 2002; 14(2): 161 - 166.
[Abstract] [Full Text] [PDF]

Home page
 J Geriatr Psychiatry NeurolHome page
K. Y. Kim, G. M. Bader, and E. Jones
Citalopram for Verbal Agitation in Patients with Dementia
J Geriatr Psychiatry Neurol, July 1, 2000; 13(2): 53 - 55.
[Abstract] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 1999 by Harvey Whitney Books Company.